| | |
Interest Payment Dates: | | March 30, June 30, September 30 and December 30 of each year, beginning June 30, 2024 (long first coupon) |
| |
Coupon: | | 6.750% |
| |
Price to Public: | | $25.00 per Note / 100% of principal amount |
| |
Underwriter Purchase Price for Sales to Retail: | | $24.2125 per Note plus accrued interest, if any, from March 20, 2024 |
| |
Underwriter Purchase Price for Sales to Institutions: | | $24.50 per Note plus accrued interest, if any, from March 20, 2024 |
| |
Over-allotment Option: | | The underwriters may purchase up to an additional $50,000,000 aggregate principal amount of Notes for 30 days after the Trade Date in order to cover over-allotments, if any. |
| |
Optional Redemption: | | |
| |
Par Call: | | On or after March 30, 2029, in whole or in part, at 100% of the principal amount, plus any accrued and unpaid interest |
| |
Call for Tax Event: | | Prior to March 30, 2029, in whole but not in part, at 100% of the principal amount, plus any accrued and unpaid interest |
| |
Call for Rating Agency Event: | | Prior to March 30, 2029, in whole but not in part, at 102% of the principal amount, plus any accrued and unpaid interest |
| |
Optional Deferral: | | Up to 20 consecutive quarterly periods per deferral period |
| |
Listing: | | The Issuer intends to apply to list the Notes on the New York Stock Exchange and, if approved for listing, expects the Notes to begin trading within 30 days after the Settlement Date. |
| |
Net Proceeds, Before Expenses: | | $389,881,901.25 (without exercise of the Over-allotment Option) |
| |
Use of Proceeds: | | The Issuer intends to use the net proceeds of this Offering for general corporate purposes, which may include the repayment or refinancing of indebtedness, share repurchases, and investments in new and existing investment management firms. |
| |
CUSIP / ISIN: | | 008252827 / US0082528276 |
| |
Joint Book-Running Managers: | | BofA Securities, Inc. Morgan Stanley & Co. LLC RBC Capital Markets, LLC Wells Fargo Securities, LLC |